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ABSTRACT
Background Studies in the 1990s have found that periconceptional dietary folate, supplementation of folic acid or supplemental multivitamins
containing folic acid, help prevent neural tube defect (NTDs) if taken at the right time. This literature review assesses the extant folic acid
public health campaigns literature and identiﬁes some common variables used in folic acid consumption campaign evaluations.
Methods This review was part of a larger study that searched PUBMED, PsycINFO and Embase from 1976 to 2010 to identify articles related
to the psychosocial and economic impact of NTDs (especially spina biﬁda) on patients and caregivers.
Results Awareness of folic acid levels prior to conception improved post-campaign from 6 to 41%. Knowledge about consumption and
correct periconceptional use of folic acid also improved. However, in most studies more than 50% of women did not take folic acid as
prescribed. Many factors were associated with or without taking folic acid post-campaign, including incomplete outreach, prior awareness and
knowledge, closeness to pregnancy, demographics and other personal characteristics.
Conclusions Sustained campaigning to maintain awareness about and promote periconceptional consumption of folic acid in order to reduce
the incidence of NTDs is clearly needed. Additional initiatives could complement existing public health strategies.
Keywords awareness, campaigns, consumption, folic acid, knowledge
Introduction
After cardiac abnormalities, neural tube defects (NTDs) are
the second most common group of serious birth defects.
They are burdensome to patients, caregivers, healthcare
systems and society.
1,2 NTDs are the result of abnormalities
in neurulation (closure of the neural folds and neuropores
to form the neural tube), a process that is normally com-
pleted by 28 days post-conception and usually before a
woman knows she is pregnant.
3–5 Although NTDs have
multiple aetiologies, several studies in the 1990s demon-
strated that periconceptional dietary folate, supplementation
of folic acid and/or supplemental multivitamins containing
folic acid help prevent NTDs.
6
Folate is a water-soluble B vitamin that is found naturally
in foods such as fruits, dark green vegetables, potatoes,
beans and yeast extract. Folic acid is the synthetic form of
folate found in dietary supplements and added to enriched
ﬂour and grain products such as breads, pasta, rice and
cereals.
7–9 Compelling evidence about the efﬁcacy of folic
acid against NTDs emerged from two randomized con-
trolled trials.
10,11 The UK Medical Research Council trial
found that 4 mg/day of periconceptional folic acid sup-
plementation in high-risk women (recurrent NTDs) was
associated with a 72% reduction in NTD pregnancies. Later,
a Hungarian trial showed that 0.8 mg/day of folic acid in a
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ﬁrst occurrences of NTDs (low-risk women). When taken
before conception, adequate use of folic acid reduces the
incidence of NTDs by 50–70% to a rate of approximately
6 per 10 000 pregnancies.
12 However, many women are not
aware that folic acid must be taken before conception; in
addition, 40–50% of pregnancies are unplanned.
13–15
Consequently, national health bodies and clinical practice
guidelines (including those in the UK, US, Canada and
Australia) recommend an increase of periconceptional folate
intake for all women of child-bearing age and specify a folic
acid supplement of 4–5 mg per day for women at high risk
or 0.4–0.5 mg per day for women at low risk.
5,16–20 AU S
Food and Drug Association (FDA) Advisory Committee
for Reproductive Health Drugs recommended that pregnant
women (pre-pregnancy and early pregnancy) should increase
their intake of folic acid by 400 mgad a y .
21 Since the 1990s,
strategies targeting women of child-bearing age were
implemented at local and national levels to help translate
national recommendations into action.
One strategy is folate fortiﬁcation in staple foods such as
wheat ﬂour, breads and cereals. Fortiﬁcation implementation
varies widely from country to country. In 1996, the US
FDA requested that folic acid be added to all ‘enriched’
grain products to help lower the risk of folic acid preventa-
ble birth defects; this became mandatory in 1998.
22
However, in Europe there is no regulation for food fortiﬁca-
tion—although some fortiﬁed products are available in
some countries.
19,20,23 The number of countries with
documented national regulations for mandatory wheat-ﬂour
fortiﬁcation increased from 33 in 2004 to 54 in 2007.
Worldwide observation of trends indicate an increase in
wheat-ﬂour fortiﬁcation with folic acid and iron from 18%
in 2004 to 27% in 2007, with the number of individuals
with access to fortiﬁed wheat ﬂour increasing by 540 million
and the annual number of newborns whose mothers had
access during pregnancy increasing by 14 million.
24
Another strategy is public health campaigns aimed at
informing and inﬂuencing behavioral change in all individ-
uals, not just those who seek help.
25 Ofﬁcial health edu-
cation initiatives have promoted folic acid supplementation
and a diet rich in folates.
26 Campaigns range from media
communications and information kits, to free product
samples and discount vouchers, to improved labeling and
in-store displays promoting dietary sources of folic acid.
Better prenatal detection, as well as increased use of pre-
natal screening programs to terminate affected pregnancies,
has helped prevent live births with NTDs. Improved nutri-
tional awareness has contributed to the decline in incidence
of NTDs in many parts of the world.
20,27,28 However,
despite the education and fortiﬁcation measures taken to
date, research indicates that many women do not take ade-
quate amounts of folic acid pre-conception. More NTDs
and induced pregnancy terminations could be prevented if
more women took folic acid every day.
26,29
The likelihood of taking recommended preventative
health action is dependent on many factors (Fig. 1). The
health belief model (HBM) posits that individuals’ beliefs
INDIVIDUAL’S PERCEPTIONS  INFLUENCING FACTORS  ADHERENCE/LIKELIHOOD OF ACTION
Demographic variables
(age, sex, race, ethnicity, etc.)
Sociopsychological variables 
Perceived benefits of
preventive action
minus 
Perceived barriers to
preventive action
Perceived susceptibility to condition
Perceived seriousness (severity) of
condition
Perceived threat of
condition
Likelihood of taking
recommended preventive
health action
Cues to action
Mass media campaigns
Advice from others
Reminder post card from physician or
dentist
Illness of family member or friend
Newspaper or magazine article
Fig. 1 HBM for predicting and explaining likelihood of taking recommended preventative health action.
SUCCESS FACTORS OF FA HEALTH CAMPAIGNS 91about the seriousness of a health condition and how suscep-
tible they are to that condition—as well as cues to action
(such as media campaigns and advice from healthcare pro-
fessionals)—determine the overall perceived threat of a con-
dition.
30 HBM states that prior awareness of a condition
affects individuals’ perceptions of susceptibility to it; individ-
uals who are familiar with a condition may perceive them-
selves as more susceptible to the condition than those with
less knowledge about it.
31 Their appraisal of the perceived
beneﬁts versus barriers to preventative actions also plays an
important role, together with socio-psychological and demo-
graphic factors.
The objective of this paper is to assess the extant folic
acid public health campaigns literature and identify some
common variables used in folic acid consumption campaign
evaluations. Study outcomes and barriers to success for folic
acid public health campaigns are compared with other
health campaign interventions.
Methods
This literature review was part of a larger study investigating
the psychosocial and economic impact of NTDs (especially
spina biﬁda) on patients and caregivers. Examination of the
impact of campaigns on folic acid awareness and consump-
tion was not a primary objective of the larger study.
However, the search strategy identiﬁed many articles that
focused on folic acid campaigns, even though ‘campaigns’
was not part of the search strategy. Given the wealth of data
uncovered by the search, it was decided to explore the
factors inﬂuencing the success of campaigns targeting
women’s folic acid awareness and consumption.
PUBMED, PsycINFO and Embase were searched for
relevant articles dating from January 1976 to October 2010.
The review used a subject and text word-search strategy
with the following terms:
† NTDs, SB, anencephaly, meningocele AND
† Health-related quality of life, HRQoL, quality of life,
QoL symptoms, satisfaction, body image, self-image,
emotional, physical, psychological, psychosocial, self-
esteem, impact, relationships, caregiver burden, family
impact, work, productivity, absenteeism, presenteeism,
qualitative, interviews, grounded theory, interpretive phe-
nomenological analysis OR
† Cost, cost of illness, cost of disease, economic burden,
economic impact, resource use, hospitalization, unmet
need OR
† Economic evaluation, cost analysis, cost-effectiveness,
CEA, cost minimization, CMA, cost consequence, CCA,
cost utility, CUA, cost beneﬁt, CBA, cost savings, patient
preferences OR
† Folic acid, folate, vitamin supplements, food fortiﬁ*,
enriched grain OR
† Family planning, unplanned pregnancy, pre-natal care,
abortion, termination.
Additional internet and manual searches were performed to
identify other relevant published material as well as unpub-
lished material not normally found in electronic databases.
The review was restricted to English language studies.
To satisfy the initial inclusion criteria, articles had to
contain studies that were speciﬁc to an appropriate clinical
term and a reference to folic acid education and consump-
tion programs. Due to the high number of seemingly rel-
evant articles, conferences, dissertations, books or chapters
were excluded and articles were ranked for further review
according to three criteria:
† Rank 1—Journal article with a patient-reported outcome,
cost or folic acid term as the main focus of the article
and consequently reported in the title and abstract.
† Rank 2—Journal article with patient-reported outcome,
cost or folic acid term found in the title and abstract but
not main focus of the article. These studies often
reported relevant results as secondary outcomes in the
abstract.
† Rank 3—Journal article with relevant terms in the back-
ground or implied in the abstract.
Articles ranked 1 were included in the review; all other
articles were excluded. Data extraction tables were developed
to accurately summarize relevant features and results of the
selected studies. The key components of the data extraction
tables were general information about the authors, publi-
cation date, country of study and reference. The aims of the
studies, strategy/campaign/program, target sample, study
design, participants and results were also documented.
Results
Study selection
Of the 166 articles initially identiﬁed (4456 abstracts
screened and 4288 excluded), 38 articles were relevant to
health campaigns. Ten articles focused on pre- and
post-campaign awareness, knowledge or consumption data
for women of child-bearing age.
32–41 The remaining 28
articles focused on data at one time point, trend analysis
and/or factors associated with awareness, knowledge or
consumption of folic acid.
6,12,42–67 Data were collected at
time points ranging from 2 days
39 to 4 years following
pre-assessment.
33,40
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and consumption of folic acid
All 38 articles assessed awareness, knowledge and/or
consumption of folic acid; our results are summarized
below accordingly.
Awareness
The majority of articles deﬁned awareness as whether
women had heard of folic acid.
32,34,35,37,38,57,58Results
showed that awareness of folic acid improved post-
campaign, with the percentage improvement between pre-
and post-campaigns ranging from 6
34 to 41%.
57
Women most often learned about folic acid from public
media (particularly TV
66) or learning about a celebrity/
famous person who had a child with a disability.
58 This was
followed by learning from pro-active healthcare pro-
fessionals, and then friends and relatives, especially those
with a child with an NTD.
34,42,59,68
Knowledge
Several studies explored women’s knowledge about folic acid,
including understanding its role in preventing birth defects
(Fig. 2 and Fig. 3)
32,34,35,39,40,56,57, food sources and sup-
plementation,
34,35,37,40 and timing of consumption.
34,35,37,42
Although knowledge regarding appropriate sources of
folic acid (foods or supplements) improved post-campaign,
in most studies ,50% of women were able to provide
details about supplements that contained folic acid.
34,35,40
However, one US study found a high proportion of
women were knowledgeable about food and supplements.
92%
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Fig. 2 Folic acid awareness before and after campaign by country.
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Fig. 3 Folic acid consumption before and after campaign by country (around time of conception).
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post-campaign survey that they had heard about folic acid,
knowledge about the ways to increase consumption
increased from 55% in 1997 to 73% in 1999 but correct
knowledge about the best time to take folic acid (before or
during pregnancy) did not increase.
42 A recent Danish study
reported that pregnant women who actually use folic acid
supplements signiﬁcantly outnumber those who simply
‘declare their knowledge of folic acid supplementation’.
59
Nevertheless, educational campaigns can be effective.
One US study found that when women aged 18–45 partici-
pated in a 15-min computerized educational session, the
percentage of women who understood that folate can
prevent birth defects rose from 26% pre-campaign to 92%
post-campaign.
67 In general, women’s knowledge about folic
acid’s role in preventing birth defects and about food and
supplemental sources of folic acid improved after campaigns
but women were less likely to understand the importance of
taking folic acid before conception.
Consumption
In general, folic acid consumption rose between 12.4
36 and
25.3% after public health campaigns.
32 Nevertheless, the
percentage of women taking periconceptional folic acid as
prescribed ranged from 13 to 57%. This suggests .43% of
women were not taking folic acid as prescribed after
campaigns ceased.
32,33,36,38–41,57
Acknowledged barriers to the success of
campaigns
Since results of public health campaigns are mixed in terms
of raising appropriate consumption of folic acid, it is essen-
tial to identify factors contributing to the success—or
failure—of these programs. The following factors were
identiﬁed.
Incomplete outreach
Campaigns increased awareness and knowledge of folic acid
consumption; however it must be recognized that a con-
siderable proportion of the intended population may not
have understood or even witnessed the campaign or its key
messages for a variety of reasons. For example, women who
do not have a television or who do not read magazines may
not have been reached by those campaigns’.
58,63
Prior awareness and knowledge
Prior knowledge and awareness of folic acid has been linked
to whether patients use it.
36,40 One study found that partici-
pants who had heard of folic acid before (awareness) were
more likely to believe in its beneﬁts than those who had
not.
56 Patient knowledge was also linked to beliefs, which
ultimately inﬂuenced consumption. For example, in studies
exploring women’s awareness and consumption of folic acid
for the prevention of NTDs, women who saw ‘perceived
beneﬁts’ of taking folic acid made statements like the
following:
56
‘Even if she is not planning a pregnancy every woman
capable of becoming pregnant should take folic acid
supplements.’
‘It is easy to consume the recommended amount of folic
acid through vitamin supplements.’
‘When one is pregnant, one has to take it [folic acid] when
the baby’s brain is forming. That’s an important vitamin.’
40
‘Perceived barriers’ to taking folic acid included women who
did not perceive risk due to medical history or diet and
made these following types of statements:
56
‘If someone does not have a family history of neural tube
defects, she is not at risk of having a baby with a neural
tube defect.’
‘I don’t need to take folic acid supplements because I get
enough in my diet.’
Closeness to pregnancy
Closeness to pregnancy (deﬁned as planning a pregnancy,
currently pregnant or giving birth within the last 12 months)
was a factor in the use of folic acid supplements post-
campaign.
35,38 However, in one study only a small pro-
portion (4.7%) of women planning pregnancy took folic
acid every day as opposed to no vitamin supplementation.
35
Two studies found that women with an unplanned preg-
nancy were less likely to have used folic acid compared with
other women in the study populations.
36,46
Demographic and other personal characteristics
Women who took folic acid were usually older,
51,52
Caucasian,
39 married,
38 educated,
32,34,35,51,69 non-
smokers
34,39,51 and of high socio-economic status.
51
Research in Puerto Rico using a questionnaire to assess folic
acid use found that highly educated women were 8.3 times
more likely to consume folic acid.
66 In addition to socioeco-
nomic factors, an Israeli study focusing on use of preconcep-
tional folic acid reported that religion was a contributing
factor. In particular, the Jewish population exhibited signiﬁ-
cantly higher rates of folic acid utilization compared with the
Arab group (Muslim Arab, Christian Arab and Druze).
32
94 JOURNAL OF PUBLIC HEALTHParous state (having given birth to one or more child) also
increased a woman’s likelihood of taking folic acid.
34,51
Discussion
Main ﬁndings of this study
This review found that awareness, knowledge and consump-
tion of folic acid improved following public health cam-
paigns; however, these results were mixed. Knowledge about
the beneﬁts and sources of folic acid increased post-
campaign, but most women misunderstood the appropriate
time to self-administer folic acid. With the exception of one
US study, ,50% of women could correctly cite the types of
food containing folic acid, and generally ,50% of women
of child-bearing age were actually taking folic acid.
33,36,38,57
To summarize, these campaigns usually changed the knowl-
edge and behavior of less than half the target population.
The review also identiﬁed factors that impact consump-
tion of folic acid, including incomplete outreach, prior
awareness and knowledge, closeness to pregnancy, demo-
graphics and other personal characteristics. This information
can help identify target groups not currently reached by
campaigns and can be used to design health promotion
strategies accordingly.
What is already known about this topic?
Despite folic acid’s clear link with NTD prevention, folic
acid education campaigns worldwide have had mixed results
in terms of knowledge about the beneﬁts and sources of
folic acid, and especially in terms of understanding the
correct, periconceptional timing of folic acid intake. These
mixed results for folic acid campaigns are consistent with
the broader context of health campaign research. For
example, a systematic UK review in 2010 found little evi-
dence that UK public health campaigns affected health and
social outcomes, and acknowledged the difﬁculties of chan-
ging clinical behavior.
70,71 Current research on the topic
suggests that campaigns and health interventions need to
focus upon and understand the ‘drivers’ of health-seeking
behavior, i.e. the prevailing socio-political, cultural and econ-
omic contexts.
72,73
What this study adds
This review synthesizes the published quantitative and quali-
tative literature regarding public health campaigns and the
uptake of folic acid. New qualitative insights emerged from
an analytical review and interpretation of data. The research-
ers categorized information and data meaningful groups and
found the following.
Prospects for targeted educational initiatives
This review identiﬁed factors that affect the success of folic
acid education campaigns, including incomplete outreach,
prior awareness and knowledge, closeness to pregnancy,
demographics and other personal characteristics. This infor-
mation can help identify target groups not currently reached
by campaigns and can be used to design health promotion
strategies accordingly.
For example, one study proposes culturally relevant and
speciﬁc campaigning (e.g. billboards depicting different eth-
nicities and age groups) and ‘shock tactic’ campaigns (e.g.
depicting children with NTDs and life with an NTD) tar-
geted to populations not yet reached by previous
campaigns.
21
Other initiatives might target women based on age. For
example, several studies found older women planning a
pregnancy are more receptive to recommendations, but
should be educated about taking folic acid as prescribed.
Young women (16–24 years) who are not considering preg-
nancy were found to be less interested in folic acid rec-
ommendations to improve pregnancy outcomes.
13–15 Health
promotion strategies for this cohort could focus on adopt-
ing folic acid supplementation as a ‘healthy lifestyle’ habit
rather than as a ‘periconceptional’ supplement.
Prospects for targeted supplementation
Because this review conﬁrmed that folic acid campaigns—
like most health education campaigns—have mixed results,
additional supplementation initiatives should be considered.
For example, in 2003, an FDA Advisory Committee dis-
cussed the public health issues and clinical beneﬁt of com-
bining folic acid and an oral contraceptive to complement
public health efforts to reduce NTDs. In October 2010, the
ﬁrst and only oral contraceptive approved by the FDA to
raise folate levels in women (Beyaz) was launched in the
USA. This could be extremely beneﬁcial to those who begin
trying to conceive immediately after stopping oral contracep-
tive use. Many women do not inform their healthcare provi-
der when they stop taking oral contraceptives. Consequently,
they may not be informed about the importance of folic
acid supplementation until their ﬁrst pre-natal visit, which
often occurs after the neural tube should have closed.
If implemented, targeted folic acid supplementation strat-
egies like these, in addition to food/supplementary fortiﬁca-
tion, could contribute towards achieving the 2010 US
Department of Health and Human Services ‘healthy people
objectives’ for NTDS; namely, to: (i) reduce the number of
NTDs and (ii) ensure that women have appropriate folate
levels prior to conception.
74
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Results from this review provide some evidence to support
the HBM. As suggested by the HBM, women assess the
seriousness and severity of having a baby with an NTD, as
well as their susceptibility to the condition. Exposure to
public health campaigns was found to contribute in part
towards women’s awareness and their overall perceived
threat of the condition. In addition, the perceived beneﬁts
minus the various barriers to preventive action (including
prior awareness and knowledge, incomplete outreach, close-
ness to pregnancy and demographic characteristics) also help
explain the likelihood that women will take the correct
amount of folic acid preconception.
However, it should be noted that the HBM has been criti-
cized for not adequately considering the role of social and
economic environments in explaining health behaviors.
75
Other social cognition models, such as the theory of
planned behavior (TPB) may enhance understanding of the
efﬁcacy of folic acid public health campaigns.
76–78 For
example, the TPB suggests that attitudes, subjective norms
and perceived behavioral control predict behavioral inten-
tions, which in turn are associated with health behaviors.
Further, health communication research may address other
reasons why awareness, knowledge and consumption of
folic acid did not increase uniformly among the targeted
audiences in the 38 studies considered.
79
Limitations of this study
This review was part of a larger study that explored the psy-
chosocial and economic impact of NTDs (especially spina
biﬁda) on patients and caregivers. It was not speciﬁcally
designed to capture all studies on folic acid campaigns or
educational programs. Consequently, there might be other
studies not captured in this review.
Because of the study design, the current ﬁndings provide
an overview of folic acid campaigns worldwide, rather than
by country. Closer examination of country-speciﬁc issues
may reveal important differences to consider in future
research. For example, exposure to campaigns can vary
according to country-speciﬁc beliefs about the beneﬁts and
side effects of folic acid. In the US, food fortiﬁcation is
mandatory and all women of child-bearing age are rec-
ommended to take folic acid supplements. However, in the
Netherlands, women of child-bearing age who are not plan-
ning to conceive are not advised to increase their folate
intake (taking supplements only when planning to conceive)
and folic acid fortiﬁcation was outlawed. Given the limited
success of campaigns to increase the uptake of folic acid,
increased understanding of cross-cultural beliefs regarding
food fortiﬁcation is warranted. Better understanding of
these beliefs could enhance future food (or other) fortiﬁca-
tion communication strategies internationally.
‘The long-term effects of public health campaigns have
not been studied in the research reported here. Campaign
lengths spanned from 2 days
39 to 4 years.
34 Though we did
not see a difference by campaign length, one could presume
that longer campaigns would yield better outcomes.
However, as campaigns close new generations of women
may miss the messages of these campaigns.’
Furthermore, education campaigns usually occur over dis-
crete periods of time.
33,40 Thus, campaigns that were widely
disseminated in the early to mid-1990s are unlikely to
have reached a sub-section of the current target audience of
15–30 year olds in 2008. Clearly, sustained education pro-
grams are needed to maintain awareness, knowledge and
consumption of folic acid pre-conception.
Finally, while our ﬁndings identiﬁed a number of factors
contributing to consumption of folic acid, it is important to
acknowledge that because our study was not designed to be
an exhaustive literature search, there may be other factors
not identiﬁed in this review.
Future research
While this study supports the HBM and deems it appropri-
ate to undergird future public health campaigns promoting
folic acid consumption, the HBM alone cannot necessarily
explain or justify why behavior leads to action in health be-
havior. Future research could address models that help
predict and explain health behavior change such as the
transtheoretical model (TTM).
80 The TTM could provide
information on how folic acid consumption behavior might
change or be maintained.
Conclusion
Many factors contribute to the success of folic acid public
health campaigns, including identifying target groups not
currently reached by existing campaigns culturally and adapt-
ing campaigns to make them relevant to those target
groups, would likely increase the effectiveness of campaigns.
Inclusion of folic acid beneﬁts within high school and uni-
versity educational programs would also ensure the message
reaches women early in their sexual lives. Furthermore, folic
acid fortiﬁcation in food stuffs and medical products would
complement existing public health initiatives. While variables
that prove to be barriers to campaigns such as incomplete
outreach inevitably need to be overcome, further campaigns
are needed to promote and maintain awareness of the
96 JOURNAL OF PUBLIC HEALTHcorrect time to take folic acid to reduce the overall incidence
of NTDs.
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